Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Syrris to Further Extend its Global Outreach with new Distributors Across Europe, Asia and the Middle East

Published: Thursday, December 06, 2007
Last Updated: Thursday, December 06, 2007
Bookmark and Share
Syrris has appointed three sales and customer support personnel and six distributors to support its new modular flow chemistry and synthesis systems.

Record orders have spurred Syrris to further expand its sales and support team and extend its global outreach with new distributors across, Europe, Asia and the Middle East.

Syrris has announced the appointment of three sales and customer support personnel and a further six distributors to support the growing interest in its new modular flow chemistry (FRX) and synthesis (Atlas) systems. Suitable for a range of applications, Atlas has attracted the attention of many chemists worldwide and has grown to become Syrris’s leading product.

Since their launch in 2006, the FRX and Atlas systems have gone from strength to strength. With systems installed in major pharma companies and academic institutions across Europe, Asia and the US, Syrris has embarked on a series of recruitment initiatives to meet the needs of new and existing markets.

Syrris’ US-based Commercial Director, Richard Gray said “Following such a good year, in fact a record year for Syrris, we are of course very pleased. However, we are also keen to maintain our high level of customer service for which we are well known, and want to expand our offering to meet the needs of new customers in emerging markets and more distant locations. The strategic decision to expand our team and recruit new distributors will allow us to make the most of the new opportunities arising and will compliment our existing set-up”.

The new recruits will provide extra sales and support for customers throughout the South, South East and Mid West USA, the UK, Ireland, France, Switzerland, Germany, Benelux, Italy, Spain, Portugal, and Scandinavia.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Syrris Invites Chemists to Join Free Flow Chemistry Workshop in the US
Syrris is hosting a free flow chemistry workshop in Cambridge, Massachusetts, USA, on the 9th of May 2013.
Monday, April 22, 2013
Syrris Acclaimed for Latin American Presence
Extensive progress acknowledged following the opening of the Brazilian subsidiary.
Saturday, October 09, 2010
Syrris Announces Outstanding Success Following Expansion of Worldwide Operations
The Company has experienced strong 2010 start by opening its Brazilian subsidiary and new product launches.
Friday, July 16, 2010
Syrris to Host Technical Seminars in India for R&D Chemists
Applications-focused seminars to explore calorimetry, sonocrystallization and flow chemistry solutions.
Monday, May 10, 2010
Syrris Establishes Indian Subsidiary
Company expands its sales network and service support for all customers in India.
Monday, July 27, 2009
Academics Get to Test Flow Chemistry System for Free
Syrris has announced the winners of its competition to win the use of its new FRX300 flow chemistry system.
Monday, October 22, 2007
Win a Flow Chemistry System
Syrris is providing scientists with the opportunity to win one month’s free use of one of its FRX systems, the FRX300, including delivery, training and system support.
Monday, June 18, 2007
Syrris Announce new West Coast Office
To meet the growing Customer demand, Syrris expands its US sales and customer service team with the opening of an office in La Jolla, CA, to provide support for its modular flow chemistry and synthesis products.
Thursday, March 15, 2007
Buoyant Order Book Spurs Recruitment Drive at Syrris
Syrris to double sales force for its FRX and atlas as these systems demonstrate the success of the modular approach.
Tuesday, January 30, 2007
Syrris Appointed as North American Distributor of Lara and Coflux Product Lines
Syrris will be exhibiting Lara and Coflux at the forthcoming Cambridge Healthcare Institute Process R&D Summit in Philadelphia.
Monday, October 03, 2005
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!